
LeXso Nipah Virus solution provides ultra-sensitive, same-day genomic surveillance by combining high-speed hybrid capture with automated workflows to power rapid outbreak response across Asia.


Transform AML MRD research with a high-fidelity NGS solution that delivers ultra-sensitive results and same-day turnaround while minimizing sequencing noise.


Detect unintended large deletions in CRISPR-edited cells, ensuring compliance with the latest FDA genomic integrity standards.


LeXso enables ultra-sensitive liquid biopsy and MRD results with a one-hour rapid capture.


Simultaneously profile genetic and epigenetic signatures from a single sample without DNA degradation.


Streamline high-resolution embryonic aneuploidy screening with a rapid, automated single-cell workflow.
